Form 4: Marvell Technology Executive Sells 6,000 Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Chris Koopmans, EVP and Chief Operations Officer at Marvell Technology, sold 6,000 shares of common stock at $122.50 per share on December 16, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

  • Chris Koopmans, an Executive Vice President and Chief Operations Officer at Marvell Technology, sold 6,000 shares of the company's common stock.
  • The sale occurred on December 16, 2024, at a price of $122.50 per share.
  • The transaction was executed under a pre-arranged 10b5-1 trading plan established on June 17, 2024.
  • Following the sale, Koopmans directly owns 0 shares and indirectly owns 97,244 shares through a family trust.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to an executive's stock sale under a pre-arranged plan. It does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine filing related to insider trading activity. It is common for executives to use 10b5-1 plans to sell shares to avoid accusations of insider trading.

Comparison to Industry Standards

  • Sales by executives under 10b5-1 plans are a common practice across the technology industry, including companies like Nvidia, AMD, and Intel.
  • The volume of shares sold is relatively small compared to the total outstanding shares of Marvell Technology, which is typical for these types of transactions.
  • The price of $122.50 per share is within the normal trading range for Marvell stock at the time of the transaction.

Stakeholder Impact

  • The sale of shares by an executive may have a minor impact on shareholder sentiment, but it is unlikely to have a significant effect due to the pre-planned nature of the transaction.

Key Dates

DateDescription
06/17/2024Date the 10b5-1 trading plan was established.
12/16/2024Date of the stock sale transaction.
12/17/2024Date the Form 4 was signed.

Keywords

Marvell Technology, insider trading, stock sale, Form 4, 10b5-1 plan, Chris Koopmans, executive transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.